Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trial

This community-randomized controlled trial was initiated to assess the overall and herd effects of 2 different human papillomavirus (HPV) immunization strategies in over 80,000 girls and boys aged 12–15 y in 33 communities in Finland (ClinicalTrials.gov NCT00534638). Overall, 14,838 adolescents rece...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hum Vaccin Immunother
Auteurs principaux: Lehtinen, Matti, Eriksson, Tiina, Apter, Dan, Hokkanen, Mari, Natunen, Kari, Paavonen, Jorma, Pukkala, Eero, Angelo, Maria-Genalin, Zima, Julia, David, Marie-Pierre, Datta, Sanjoy, Bi, Dan, Struyf, Frank, Dubin, Gary
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2016
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215585/
https://ncbi.nlm.nih.gov/pubmed/27841725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1183847
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires